{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:43:37Z","timestamp":1793727817724,"version":"4.6.1"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116462","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T10:10:57Z","timestamp":1714299057000},"page":"116462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Update on the development of TGR5 agonists for human diseases"],"prefix":"10.1016","volume":"271","author":[{"given":"Wangrui","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-7980","authenticated-orcid":false,"given":"Yihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116462_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40168-019-0712-8","article-title":"The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile","volume":"7","author":"Molinero","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.ejmech.2024.116462_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/acscentsci.9b00147","article-title":"Chemoproteomic profiling of gut microbiota-associated bile salt hydrolase activity","volume":"5","author":"Parasar","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2024.116462_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41589-020-0467-3","article-title":"Development of a covalent inhibitor of gut bacterial bile salt hydrolases","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116462_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejmech.2024.116462_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2024.116462_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117401","article-title":"Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice","volume":"320","author":"Zheng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jgh.15709","article-title":"Altered bile acid glycine : taurine ratio in the progression of chronic liver disease","volume":"37","author":"Chen","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116462_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","article-title":"Emerging roles of bile acids in mucosal immunity and inflammation","volume":"12","author":"Chen","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejmech.2024.116462_bib11","article-title":"Research progress of bile acids in cancer","volume":"11","author":"Fu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2024.116462_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26795-7","article-title":"A bile acid-related prognostic signature in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116462_bib13","doi-asserted-by":"crossref","first-page":"s87","DOI":"10.5604\/01.3001.0010.5501","article-title":"Bile acids and cancer: direct and environmental-dependent effects","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion","volume":"13","author":"Hu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib15","doi-asserted-by":"crossref","first-page":"G55","DOI":"10.1152\/ajpgi.00476.2020","article-title":"Dynamics of the enterohepatic circulation of bile acids in healthy humans","volume":"321","author":"Stellaard","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","article-title":"Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease","volume":"43","author":"Jiao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116462_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejmech.2024.116462_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03602532.2012.740048","article-title":"Nuclear receptors in bile acid metabolism","volume":"45","author":"Li","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2024.116462_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bph.12426","article-title":"GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation","volume":"171","author":"Lieu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12072-015-9656-7","article-title":"Bile acids: emerging role in management of liver diseases","volume":"9","author":"Asgharpour","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejmech.2024.116462_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111678","article-title":"Recent advances on FXR-targeting therapeutics","volume":"552","author":"Panzitt","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116462_bib23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib24","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-020-2569-1","article-title":"Structural basis of GPBAR activation and bile acid recognition","volume":"587","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116462_bib26","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/nu12092598","article-title":"TGR5 signaling in hepatic metabolic health","volume":"12","author":"Holter","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2024.116462_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2024.116462_bib28","article-title":"Overexpression of TGR5 alleviates myocardial ischemia\/reperfusion injury via AKT\/GSK-3\u03b2 mediated inflammation and mitochondrial pathway","volume":"40","author":"Li","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2024.116462_bib29","doi-asserted-by":"crossref","first-page":"H21","DOI":"10.1152\/ajpheart.00577.2016","article-title":"Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators","volume":"312","author":"Fiorucci","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/10408398.2023.2173719","article-title":"Pectin mediates the mechanism of host blood glucose regulation through intestinal flora","author":"Guo","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ejmech.2024.116462_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","article-title":"Roles of bile acids signaling in neuromodulation under physiological and pathological conditions","volume":"13","author":"Xing","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejmech.2024.116462_bib32","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/cns.14154","article-title":"Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain","volume":"29","author":"Wu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2024.116462_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/ph16020174","article-title":"Bile acids induce neurite outgrowth in nsc-34 cells via TGR5 and a distinct transcriptional profile","volume":"16","author":"Ackerman","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116462_bib34","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3390\/antiox11091706","article-title":"Bile acids induce alterations in mitochondrial function in skeletal muscle fibers","volume":"11","author":"Abrigo","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2024.116462_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40659-023-00436-3","article-title":"Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells","volume":"56","author":"Abrigo","year":"2023","journal-title":"Biol. Res."},{"key":"10.1016\/j.ejmech.2024.116462_bib36","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016203","article-title":"Muscle-specific TGR5 overexpression improves glucose clearance in glucose-intolerant mice","volume":"296","author":"Sasaki","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib37","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1172\/JCI76289","article-title":"TGR5 reduces macrophage migration through mTOR-induced C\/EBP\u03b2 differential translation","volume":"124","author":"Perino","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116462_bib38","doi-asserted-by":"crossref","first-page":"G527","DOI":"10.1152\/ajpgi.00388.2012","article-title":"Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA\/Rho kinase pathway","volume":"304","author":"Rajagopal","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1268865","article-title":"Bile acid signalling and its role in anxiety disorders","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116462_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2024.116462_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2024.116462_bib42","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells","volume":"45","author":"Keitel","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2024.116462_bib43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"1864","author":"Deutschmann","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2024.116462_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0038-1669940","article-title":"Role of TGR5 (GPBAR1) in liver disease","volume":"38","author":"Keitel","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejmech.2024.116462_bib45","first-page":"898","article-title":"Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway","volume":"18","author":"Qi","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116462_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2337\/db18-0315","article-title":"TGR5 activation promotes stimulus-secretion coupling of pancreatic \u03b2-cells via a PKA-dependent pathway","volume":"68","author":"Maczewsky","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2024.116462_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2015.10.021","article-title":"The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP\/PKA pathway in pancreatic beta cells","volume":"65","author":"Vettorazzi","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2024.116462_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2274124","article-title":"Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microb."},{"key":"10.1016\/j.ejmech.2024.116462_bib51","article-title":"TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload","volume":"3","author":"Bidault-Jourdainne","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ejmech.2024.116462_bib52","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/cells8111467","article-title":"The G protein-coupled bile acid receptor TGR5 (Gpbar1) modulates endothelin-1 signaling in liver","volume":"8","author":"Klindt","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2024.116462_bib53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.tem.2023.08.002","article-title":"The emerging role of bile acids in white adipose tissue","volume":"34","author":"Schmid","year":"2023","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116462_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41467-017-02068-0","article-title":"TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue","volume":"9","author":"Velazquez-Villegas","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib55","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.26463","article-title":"The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice","volume":"58","author":"P\u00e9an","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2024.116462_bib56","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3390\/ani13233714","article-title":"Modulation of in vitro macrophage responses via primary and secondary bile acids in dogs","volume":"13","author":"Manchester","year":"2023","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.ejmech.2024.116462_bib57","doi-asserted-by":"crossref","first-page":"G322","DOI":"10.1152\/ajpgi.00216.2019","article-title":"TGR5 signaling mitigates parenteral nutrition-associated liver disease","volume":"318","author":"Willis","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110004","article-title":"Deoxycholic acid inhibits Staphylococcus aureus-induced endometritis through regulating TGR5\/PKA\/NF-\u03baB signaling pathway","volume":"118","author":"Zhao","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.116462_bib59","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/02698811221089041","article-title":"Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5\/AKT\/NF-\u03baB signaling pathway","volume":"36","author":"Zhu","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115900","article-title":"Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease","volume":"218","author":"Biagioli","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib61","article-title":"TGR5 activation ameliorates mitochondrial homeostasis via regulating the pkc\u03b4\/Drp1-HK2 signaling in diabetic retinopathy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2024.116462_bib62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s42255-021-00398-4","article-title":"Central anorexigenic actions of bile acids are mediated by TGR5","volume":"3","author":"Perino","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2024.116462_bib63","first-page":"745","article-title":"Ginkgo biloba extract protects against depression-like behavior in mice through regulating gut microbial bile acid metabolism","volume":"21","author":"Zhou","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116462_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12929-020-00656-9","article-title":"Activation of TGR5 protects blood brain barrier via the BRCA1\/Sirt1 pathway after middle cerebral artery occlusion in rats","volume":"27","author":"Liang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2024.116462_bib65","first-page":"639","article-title":"T2DM remission \u2014 consensus on definition","volume":"17","author":"Greenhill","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116462_bib66","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/dom.12648","article-title":"Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion","volume":"18","author":"Hansen","year":"2016","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejmech.2024.116462_bib67","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","article-title":"Gut liver brain axis in diseases: the implications for therapeutic interventions","volume":"8","author":"Yan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116462_bib68","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","author":"Zeng","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2024.116462_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154982","article-title":"Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway","volume":"119","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116462_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.metabol.2019.07.003","article-title":"TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice","volume":"99","author":"Huang","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2024.116462_bib71","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00062.2020","article-title":"Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice","volume":"318","author":"Hunt","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib72","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.apsb.2023.11.011","article-title":"Mechanism of action of the bile acid receptor TGR5 in obesity","volume":"14","author":"Lun","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2024.116462_bib73","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/en.2015-1551","article-title":"Intestinal bile acid composition modulates Prohormone convertase 1\/3 (PC1\/3) expression and consequent GLP-1 production in male mice","volume":"157","author":"Morimoto","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2024.116462_bib74","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.3390\/molecules28155870","article-title":"Research progress of Takeda G protein-coupled receptor 5 in metabolic syndrome","volume":"28","author":"Gou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116462_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109405","article-title":"Ginsenoside compound K increases glucagon-like peptide-1 release and L-cell abundance in db\/db mice through TGR5\/YAP signaling","volume":"113","author":"Tian","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.116462_bib76","article-title":"Altered glucagon and GLP-1 responses to oral glucose in children and adolescents with obesity and insulin resistance","author":"Stinson","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2024.116462_bib77","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.3390\/nu14163413","article-title":"Saponins from camellia sinensis seeds stimulate GIP secretion in mice and STC-1 cells via SGLT1 and TGR5","volume":"14","author":"Zhu","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2024.116462_bib78","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molmet.2018.03.007","article-title":"Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas","volume":"11","author":"Kuhre","year":"2018","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116462_bib79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphys.2014.00420","article-title":"Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac\/PLC-\u03b5 pathway and modulated by endogenous H2S","volume":"5","author":"Bala","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib80","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.immuni.2016.10.009","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2024.116462_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40429-019-00253-3","article-title":"Tobacco smoking, eating behaviors, and body weight: a review","volume":"6","author":"Chao","year":"2019","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.ejmech.2024.116462_bib82","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2024.116462_bib83","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/s42255-023-00938-0","article-title":"Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes","volume":"5","author":"Parker","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2024.116462_bib84","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fendo.2018.00447","article-title":"Brown adipose tissue energy metabolism in humans","volume":"9","author":"Carpentier","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116462_bib85","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3390\/ijms21083020","article-title":"Thermogenesis in adipose tissue activated by thyroid hormone","volume":"21","author":"Yau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116462_bib86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/apt.17846","article-title":"Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Loomba","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.116462_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417514","article-title":"Mitochondrial dysfunction in metabolic dysfunction fatty liver disease (MAFLD)","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116462_bib88","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41401-022-00860-3","article-title":"Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis","volume":"43","author":"Yang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116462_bib89","first-page":"9","article-title":"Age, BMI, and type2 diabetes modify the relationship between PNPLA3 and advanced fibrosis in children and adults with NAFLD","volume":"12","author":"Jarasvaraparn","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib90","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.116462_bib91","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.niox.2019.10.008","article-title":"Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids","volume":"94","author":"Guizoni","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2024.116462_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1114","article-title":"Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy","volume":"11","author":"Jin","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.ejmech.2024.116462_bib93","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000350","article-title":"Aging aggravates liver fibrosis through downregulated hepatocyte SIRT1-induced liver sinusoidal endothelial cell dysfunction","volume":"8","author":"Dai","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/biom8040159","article-title":"Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart","volume":"8","author":"Hanafi","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.116462_bib95","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2024.116462_bib96","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1152\/ajpendo.00278.2023","article-title":"An extended minimal model of OGTT: estimation of alpha- and beta-cell dysfunction, insulin resistance, and the incretin effect","volume":"326","author":"Subramanian","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2024.116462_bib97","doi-asserted-by":"crossref","first-page":"G412","DOI":"10.1152\/ajpgi.00300.2018","article-title":"Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice","volume":"316","author":"Finn","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib98","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fphys.2016.00646","article-title":"TGR5, not only a metabolic regulator","volume":"7","author":"Guo","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2024.116462_bib99","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00011-022-01629-4","article-title":"Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis","volume":"71","author":"Shao","year":"2022","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2024.116462_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104333","article-title":"Semisynthetic bile acids: a new therapeutic option for metabolic syndrome","volume":"146","author":"Lazarevi\u0107","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116462_bib101","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/jc.2011-2329","article-title":"Plasma bile acids are associated with energy expenditure and thyroid function in humans","volume":"97","author":"Ockenga","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116462_bib102","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41401-023-01081-y","article-title":"TGR5 agonist inhibits intestinal epithelial cell apoptosis via cAMP\/PKA\/c-FLIP\/JNK signaling pathway and ameliorates dextran sulfate sodium-induced ulcerative colitis","volume":"44","author":"Yang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116462_bib103","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2982.2010.01487.x","article-title":"Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system","volume":"22","author":"Poole","year":"2010","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejmech.2024.116462_bib104","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.116462_bib105","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1073\/pnas.1821111116","article-title":"Role for nuclear interleukin-37 in the suppression of innate immunity","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116462_bib106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.intimp.2019.01.021","article-title":"Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling","volume":"71","author":"Chen","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.116462_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41420-021-00589-8","article-title":"Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116462_bib108","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.116462_bib109","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.116462_bib110","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/med.21886","article-title":"Targeting key proteins involved in transcriptional regulation for cancer therapy: current strategies and future prospective","volume":"42","author":"Pei","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116462_bib111","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1021\/acs.jmedchem.2c00004","article-title":"Discovery of 2-Amino-3-cyanothiophene derivatives as potent STAT3 inhibitors for the treatment of osteosarcoma growth and metastasis","volume":"65","author":"Jin","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib112","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1021\/acs.jmedchem.2c01554","article-title":"Discovery of a highly potent and orally bioavailable STAT3 dual phosphorylation inhibitor for pancreatic cancer treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib113","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2024.116462_bib114","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2017.10.017","article-title":"The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2\/STAT3 signaling pathway in non-small cell lung cancer","volume":"412","author":"Liu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116462_bib115","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.26019","article-title":"Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2024.116462_bib116","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.3390\/molecules27165292","article-title":"The bile acid membrane receptor TGR5 in cancer: friend or foe?","volume":"27","author":"Qi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116462_bib117","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/jcm8091391","article-title":"Smoking as an independent risk factor for hepatocellular carcinoma due to the \u03b17-nachr modulating the JAK2\/STAT3 signaling Axis","volume":"8","author":"Li","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2024.116462_bib118","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.116462_bib119","doi-asserted-by":"crossref","first-page":"34402","DOI":"10.18632\/oncotarget.5353","article-title":"The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway","volume":"6","author":"Guo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116462_bib120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41420-020-0290-3","article-title":"TGR5-HNF4\u03b1 axis contributes to bile acid-induced gastric intestinal metaplasia markers expression","volume":"6","author":"Ni","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2024.116462_bib121","first-page":"3567","article-title":"High expression of TGR5 predicts a poor prognosis in patients with pancreatic cancer","volume":"11","author":"Zhao","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2024.116462_bib122","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4161\/cc.21029","article-title":"Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation","volume":"11","author":"Casaburi","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2024.116462_bib123","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.jmedchem.1c00851","article-title":"Identification of betulinic acid derivatives as potent TGR5 agonists with antidiabetic effects via humanized TGR5(H88Y) mutant mice","volume":"64","author":"Yun","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib124","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm901390p","article-title":"Discovery of 6\u03b1-ethyl-23(S)-methylcholic acid (S-emca, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity","volume":"52","author":"Pellicciari","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2024.116462_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105588","article-title":"Discovery of novel cholic acid derivatives as highly potent agonists for G protein-coupled bile acid receptor","volume":"120","author":"Qian","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib127","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm901390p","article-title":"Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity","volume":"52","author":"Pellicciari","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/ml200256d","article-title":"Avicholic acid: a lead compound from birds on the route to potent TGR5 modulators","volume":"3","author":"Pellicciari","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116462_bib129","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1021\/acs.jmedchem.9b00770","article-title":"7-Methylation of chenodeoxycholic acid derivatives yields a substantial increase in TGR5 receptor potency","volume":"62","author":"Nakhi","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib130","article-title":"Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis","volume":"66","author":"Jia","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ejmech.2024.116462_bib131","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1021\/jm501273r","article-title":"Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands","volume":"57","author":"Festa","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib132","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1021\/jm500889f","article-title":"Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1)","volume":"57","author":"Sepe","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115169","article-title":"A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters","volume":"404","author":"Wang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib134","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/acsmedchemlett.9b00636","article-title":"GPBAR1 activation by C6-substituted hyodeoxycholane analogues protect against colitis","volume":"11","author":"Marino","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116462_bib135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13543776.2022.1994551","article-title":"TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present)","volume":"32","author":"Bhimanwar","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2024.116462_bib136","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/jm900872z","article-title":"Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes","volume":"53","author":"Genet","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib137","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2007.06.130","article-title":"Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea","volume":"362","author":"Sato","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib138","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/jm7015864","article-title":"Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies","volume":"51","author":"Sato","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib139","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00210-017-1409-9","article-title":"Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats","volume":"390","author":"Lo","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib140","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3389\/fphar.2017.00468","article-title":"Allspice and clove as source of triterpene acids activating the G protein-coupled bile acid receptor TGR5","volume":"8","author":"Ladurner","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179226","article-title":"Identification of key amino acid residues in the hTGR5-nomilin interaction and construction of its binding model","volume":"12","author":"Sasaki","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116462_bib142","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2011.06.055","article-title":"Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet","volume":"410","author":"Ono","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib143","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2015.06.022","article-title":"Dietary obacunone supplementation stimulates muscle hypertrophy, and suppresses hyperglycemia and obesity through the TGR5 and PPAR\u03b3 pathway","volume":"463","author":"Horiba","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116462_bib144","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/cmdc.201000329","article-title":"Redefining the TGR5 triterpenoid binding pocket at the C-3 position","volume":"5","author":"Genet","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116462_bib145","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/aps.2014.97","article-title":"Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy","volume":"35","author":"Wang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116462_bib146","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/jm901434t","article-title":"Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists","volume":"52","author":"Evans","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib147","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bmcl.2010.01.003","article-title":"Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists","volume":"20","author":"Budzik","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116462_bib148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1039\/C2MD20174G","article-title":"Optimization of triazole -based TGR5 agonists towards orally available agents","volume":"4","author":"Futatsugi","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2024.116462_bib149","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1021\/jm401731q","article-title":"Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacy","volume":"57","author":"Phillips","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib150","series-title":"Preparation of Quinoline Compounds as Modulators of TGR5 for Treatment of Disease","author":"Pinkerton","year":"2008"},{"key":"10.1016\/j.ejmech.2024.116462_bib151","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1016\/j.bmcl.2010.08.014","article-title":"Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5","volume":"20","author":"Herbert","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116462_bib152","series-title":"Preparation of Bis(arylsulfonyl)piperazine and Related Dinitrogen Moieties as Antidiabetic Agents. WO2007127505","author":"Szewczyk","year":"2007"},{"key":"10.1016\/j.ejmech.2024.116462_bib153","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cpdd.34","article-title":"Safety, pharmacokinetics, and pharmacodynamic effects of a selective TGR5 agonist, SB-756050, in type 2 diabetes","volume":"2","author":"Hodge","year":"2013","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejmech.2024.116462_bib154","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1016\/j.bmcl.2013.06.017","article-title":"Discovery and optimisation of 1-hydroxyimino-3,3-diphenylpropanes, a new class of orally active GPBAR1 (TGR5) agonists","volume":"23","author":"Dehmlow","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116462_bib155","series-title":"1-Hydroxyimino-2-phenylpropanones as GPBAR1 Agonists and Their Preparation","author":"Bissantz","year":"2012"},{"key":"10.1016\/j.ejmech.2024.116462_bib156","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bph.12158","article-title":"Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release","volume":"169","author":"Ullmer","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116462_bib157","article-title":"Preparation of aromatic ring-fused cyclic compounds as TGR5 receptor agonists","author":"Itoh","year":"2004","journal-title":"WO2004067008"},{"key":"10.1016\/j.ejmech.2024.116462_bib158","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2013.07.050","article-title":"Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold","volume":"69","author":"Zhu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib159","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cmdc.201300144","article-title":"Design, synthesis, and structure-activity relationships of 3,4,5-trisubstituted 4,5-dihydro-1,2,4-oxadiazoles as TGR5 agonists","volume":"8","author":"Zhu","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116462_bib160","series-title":"Preparation of 1,2-pyridazine, 1,6-pyridazine or Pyrimidine Substituted Benzamides as GPBAR1 Modulators","author":"Dehmlow","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116462_bib161","article-title":"3-Aminopyridines as GPBAR1 agonists and their preparation and use in the treatment of type II diabetes","author":"Bissantz","year":"2012","journal-title":"WO2012117000"},{"key":"10.1016\/j.ejmech.2024.116462_bib162","article-title":"Preparation of substituted pyridine derivatives useful as GPR131 agonists","author":"Devita","year":"2013","journal-title":"WO2013062887"},{"key":"10.1016\/j.ejmech.2024.116462_bib163","series-title":"Preparation of Bicyclic Agonists of GPR131. WO2013032939","author":"Song","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116462_bib164","article-title":"Preparation of diaryl substituted heteroaromatic compounds as agonists of G-protein coupled bile acid GPBAR1\/TGR5 receptor","author":"Sheridan","year":"2014","journal-title":"WO2014199164"},{"key":"10.1016\/j.ejmech.2024.116462_bib165","article-title":"Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity and their preparation","author":"Bollu","year":"2010","journal-title":"WO2010093845"},{"key":"10.1016\/j.ejmech.2024.116462_bib166","article-title":"Preparation of benzylsulfanylphenylimidazolylphenylmethylamine derivatives and analogs for use as TGR5 agonists","author":"Charton","year":"2015","journal-title":"WO2015189330"},{"key":"10.1016\/j.ejmech.2024.116462_bib167","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cmdc.201200474","article-title":"2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5)","volume":"8","author":"Martin","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116462_bib168","article-title":"Preparation of novel phenyl amide or pyridyl amide derivatives as GPBAR1 agonists for treating type II diabetes","author":"Bissantz","year":"2010","journal-title":"US20100105906"},{"key":"10.1016\/j.ejmech.2024.116462_bib169","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1021\/jm301071h","article-title":"Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists","volume":"55","author":"Duan","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.05.031","article-title":"4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists","volume":"82","author":"Zou","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib171","doi-asserted-by":"crossref","first-page":"11732","DOI":"10.1021\/acs.jmedchem.2c01881","article-title":"Discovery, structure-activity relationships, and in vivo activity of dihydropyridone agonists of the bile acid receptor TGR5","volume":"66","author":"Picon","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib172","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bmcl.2012.12.076","article-title":"Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries","volume":"23","author":"Londregan","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116462_bib173","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116462_bib174","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/glia.23585","article-title":"Lysophosphatidic acid activates satellite glia cells and Schwann cells","volume":"67","author":"Robering","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2024.116462_bib175","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1096\/fj.201801373RR","article-title":"Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis","volume":"33","author":"Carino","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2024.116462_bib176","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14728214.2019.1604684","article-title":"Emerging PEGylated non-biologic drugs","volume":"24","author":"Park","year":"2019","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2024.116462_bib177","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/acs.jmedchem.0c01774","article-title":"Beyond the rule of 5: impact of PEGylation with various polymer sizes on pharmacokinetic properties, structure-properties relationships of mPEGylated small agonists of TGR5 receptor","volume":"64","author":"Hoguet","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib178","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm500829b","article-title":"Discovery of intestinal targeted TGR5 agonists for the treatment of type 2 diabetes","volume":"58","author":"Duan","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib179","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1021\/acs.jmedchem.8b00308","article-title":"Design of gut-restricted thiazolidine agonists of G protein-coupled bile acid receptor 1 (GPBAR1, TGR5)","volume":"61","author":"Chen","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116462_bib180","article-title":"Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116462_bib181","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2192155","article-title":"Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes","volume":"15","author":"Chen","year":"2023","journal-title":"Gut Microb."},{"key":"10.1016\/j.ejmech.2024.116462_bib182","article-title":"A nucleic acid-based LYTAC plus platform to simultaneously mediate disease-driven protein downregulation","author":"Huang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2024.116462_bib183","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116462_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202316089","article-title":"Insulin-like growth factor 2-tagged aptamer chimeras (ITACs) modular assembly for targeted and efficient degradation of two membrane proteins","volume":"63","author":"Tian","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T00:51:43Z","timestamp":1731804703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424003428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":184,"alternative-id":["S0223523424003428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116462","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the development of TGR5 agonists for human diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116462"}}